Home › Funds › INVESTMENT MANAGEMENT ASSOCIATES INC /ADV › SPRY
INVESTMENT MANAGEMENT ASSOCIATES INC /ADV position in SPRY
ARS PHARMACEUTICALS INC · Health Care
INVESTMENT MANAGEMENT ASSOCIATES INC /ADV reported holding 393,428 shares of SPRY (ARS PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$1.7M, representing 0.35% of its reported portfolio and ranking #24 among its reported holdings. INVESTMENT MANAGEMENT ASSOCIATES INC /ADV has disclosed SPRY holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How INVESTMENT MANAGEMENT ASSOCIATES INC /ADV's SPRY position evolved
INVESTMENT MANAGEMENT ASSOCIATES INC /ADV first disclosed a stake in SPRY in Q4 2025 at 311,503 shares (US$3.6M). Across 4 filings, INVESTMENT MANAGEMENT ASSOCIATES INC /ADV increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 393,428 shares valued at US$1.7M — an increase of 19,937 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 311.50K | $3.63M | New |
| Q1 2026 | 359.07K | $2.88M | Add |
| Q2 2026 | 373.49K | $2.99M | Add |
| Q3 2026 | 393.43K | $1.70M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About SPRY and 13F data
SPRY (ARS PHARMACEUTICALS INC) is a Health Care company. 21 other funds we track also report a position in SPRY — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$87.0M), Rubric Capital Management LP (US$68.4M), ORBIMED ADVISORS LLC (US$66.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SPRY
- RA CAPITAL MANAGEMENT, L.P. 10.86M sh · $87.00M · Q2 2026
- Rubric Capital Management LP 8.54M sh · $68.41M · Q2 2026
- ORBIMED ADVISORS LLC 8.29M sh · $66.39M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 7.50M sh · $60.11M · Q2 2026
- SR ONE CAPITAL MANAGEMENT, LP 4.01M sh · $32.14M · Q2 2026
- Tyro Capital Management LLC 3.20M sh · $13.79M · Q3 2026
- Third Point 1.00M sh · $8.01M · Q2 2026
- Third Point LLC 1.00M sh · $8.01M · Q2 2026
More on INVESTMENT MANAGEMENT ASSOCIATES INC /ADV
FAQ
How long has INVESTMENT MANAGEMENT ASSOCIATES INC /ADV held SPRY?
INVESTMENT MANAGEMENT ASSOCIATES INC /ADV has disclosed SPRY holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is INVESTMENT MANAGEMENT ASSOCIATES INC /ADV's current position in SPRY?
As of Q3 2026, INVESTMENT MANAGEMENT ASSOCIATES INC /ADV holds 393.43K shares of SPRY (ARS PHARMACEUTICALS INC), valued at $1.70M, representing 0.35% of its reported portfolio and ranking #24.
Has INVESTMENT MANAGEMENT ASSOCIATES INC /ADV been buying or selling SPRY?
In the latest 13F filing (Q3 2026), INVESTMENT MANAGEMENT ASSOCIATES INC /ADV increased its position in SPRY.
Which other funds hold SPRY?
Other major institutional holders of SPRY include RA CAPITAL MANAGEMENT, L.P., Rubric Capital Management LP, ORBIMED ADVISORS LLC, among 21 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.